Amphadase FDA Approval History
FDA Approved: Yes (First approved October 26, 2004)
Brand name: Amphadase
Generic name: hyaluronidase
Dosage form: Injection
Company: Amphastar Pharmaceuticals, Inc
Treatment for: Adjuvant to increase the absorption and dispersion of other injected drugs
Amphadase (hyaluronidase) used as an adjunctive agent to facilitate the dispersion and absorption of other drugs.
Development timeline for Amphadase
| Date | Article |
|---|---|
| Oct 26, 2004 | Approval Amphadase Amphastar Pharmaceuticals, Inc - Treatment for Adjunctive Agent |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
